Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 22, 2023 Filed May 23, 2023 21:53 UTC |
HANISH ARNOLD CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $5.30 | $0.00 |
DisclosureSEC source: 0001415889-23-008651 · form4-05232023_090541.xml · derivative · entry 4 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2023-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:53 UTC |
HANISH ARNOLD CDirector
|
SaleCommon Stock | 5,000 | $6.46 | $32,300.00 |
DisclosureSEC source: 0001415889-23-008651 · form4-05232023_090541.xml · nonDerivative · entry 2 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: This transaction was executed in multiple trades at prices ranging from $6.34 to $6.61. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 22, 2023 Filed May 23, 2023 21:53 UTC |
HANISH ARNOLD CDirector
|
Exercise / conversionCommon Stock | 5,000 | $5.30 | $26,500.00 |
DisclosureSEC source: 0001415889-23-008651 · form4-05232023_090541.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2023 Filed May 16, 2023 22:35 UTC |
Perkinson Diana T.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $5.71 | $0.00 |
DisclosureSEC source: 0001415889-23-008127 · form4-05162023_100518.xml · derivative · entry 1 Perkinson Diana T. · CIK 0001976830 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2033-05-12 F1 · derivative.exercise_date: This option shall vest and become exercisable in equal annual installments over a three-year period beginning on the first anniversary of the date of grant. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:23 UTC |
Cancelmo Peter BVP, GENERAL COUNSEL
|
GrantStock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009926 · form4-09232022_050931.xml · derivative · entry 1 Cancelmo Peter B · CIK 0001778968 · VP, GENERAL COUNSEL 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:26 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
GrantStock Option (right to buy) · Derivative | 650,000 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009928 · form4-09232022_050901.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 650,000 Underlying: Common Stock · 650,000 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:35 UTC |
Cable Thomas J.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009935 · form4-09232022_050941.xml · derivative · entry 1 Cable Thomas J. · CIK 0001472158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:34 UTC |
Bumol Thomas F.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009934 · form4-09232022_050933.xml · derivative · entry 1 Bumol Thomas F. · CIK 0001767077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:33 UTC |
Shah RajivDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009933 · form4-09232022_050920.xml · derivative · entry 1 Shah Rajiv · CIK 0001642407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:32 UTC |
Demopulos Peter A MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009932 · form4-09232022_050926.xml · derivative · entry 1 Demopulos Peter A MD · CIK 0001472161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:29 UTC |
Hood Leroy E. MD PhDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009931 · form4-09232022_050927.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:28 UTC |
Zumwalt KurtDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009930 · form4-09232022_050924.xml · derivative · entry 1 Zumwalt Kurt · CIK 0001803266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:27 UTC |
HANISH ARNOLD CDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009929 · form4-09232022_050922.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 21, 2022 Filed Sep 24, 2022 00:24 UTC |
JACOBSEN MICHAEL AVP FINANCE AND CAO
|
GrantStock Option (right to buy) · Derivative | 85,000 | $0.00 Strike: $3.93 | $0.00 |
DisclosureSEC source: 0001415889-22-009927 · form4-09232022_050942.xml · derivative · entry 1 JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Common Stock · 85,000 shares Expires 2032-09-21 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2022. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:25 UTC |
Cable Thomas J.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006848 · form4-06222022_020604.xml · derivative · entry 1 Cable Thomas J. · CIK 0001472158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:28 UTC |
Demopulos Peter A MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006851 · form4-06222022_020601.xml · derivative · entry 1 Demopulos Peter A MD · CIK 0001472161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:29 UTC |
Zumwalt KurtDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006853 · form4-06222022_020619.xml · derivative · entry 1 Zumwalt Kurt · CIK 0001803266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:28 UTC |
Shah RajivDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006852 · form4-06222022_020631.xml · derivative · entry 1 Shah Rajiv · CIK 0001642407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:27 UTC |
Hood Leroy E. MD PhDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006850 · form4-06222022_020610.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:26 UTC |
HANISH ARNOLD CDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006849 · form4-06222022_020623.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 17, 2022 Filed Jun 22, 2022 21:24 UTC |
Bumol Thomas F.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-006847 · form4-06222022_020621.xml · derivative · entry 1 Bumol Thomas F. · CIK 0001767077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2032-06-17 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 17, 2022. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2023 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 21:19 UTC |
HANISH ARNOLD CDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $9.44 | $0.00 |
DisclosureSEC source: 0001415889-21-004308 · form4-09092021_020920.xml · derivative · entry 2 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 10,000 shares Expires 2022-09-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: On September 8, 2021, 2021, the reporting person paid the exercise price and exercised options to purchase a total of 10,000 shares of the company's common stock. These shares have not been sold and are held of record by the Arnold C. Hanish Living Trust, for which the reporting person serves as sole trustee. Read SEC document |
| September 08, 2021 Filed Sep 9, 2021 21:19 UTC |
HANISH ARNOLD CDirector
|
Exercise / conversionCommon Stock | 10,000 | $9.44 | $94,400.00 |
DisclosureSEC source: 0001415889-21-004308 · form4-09092021_020920.xml · nonDerivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: On September 8, 2021, 2021, the reporting person paid the exercise price and exercised options to purchase a total of 10,000 shares of the company's common stock. These shares have not been sold and are held of record by the Arnold C. Hanish Living Trust, for which the reporting person serves as sole trustee. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 01:05 UTC |
Cancelmo Peter BVP, GEN. COUNSEL & CORP. SEC.
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001415889-21-003529 · form4-07062021_090714.xml · derivative · entry 1 Cancelmo Peter B · CIK 0001778968 · VP, GEN. COUNSEL & CORP. SEC. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2021. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 01:00 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
GrantStock Option (right to buy) · Derivative | 550,000 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001415889-21-003527 · form4-07062021_090702.xml · derivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550,000 Underlying: Common Stock · 550,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2021. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| July 02, 2021 Filed Jul 7, 2021 01:05 UTC |
JACOBSEN MICHAEL AVP FINANCE AND CAO
|
GrantStock Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $14.99 | $0.00 |
DisclosureSEC source: 0001415889-21-003528 · form4-07062021_090701.xml · derivative · entry 1 JACOBSEN MICHAEL A · CIK 0001529087 · VP FINANCE AND CAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: This option shall vest and become exercisable over 48 equal monthly installments, with a vesting commencement date of April 1, 2021. Installments vest and become exercisable on each monthly anniversary thereafter. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:30 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionStock Option (right to buy) · Derivative | 36,857 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 36,857 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:30 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
SaleCommon Stock | 36,857 | $14.90 | $549,169.30 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $14.72 to $15.06; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| June 17, 2021 Filed Jun 18, 2021 00:30 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionCommon Stock | 36,857 | $4.10 | $151,113.70 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionStock Option (right to buy) · Derivative | 36,856 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · derivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,857 Underlying: Common Stock · 36,856 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
SaleCommon Stock | 36,856 | $15.02 | $553,577.12 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $14.83 to $15.45; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| June 15, 2021 Filed Jun 18, 2021 00:30 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionCommon Stock | 36,856 | $4.10 | $151,109.60 |
DisclosureSEC source: 0001415889-21-003077 · form4-06172021_080601.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:25 UTC |
Cable Thomas J.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001322 · form4-02142022_020201.xml · derivative · entry 1 Cable Thomas J. · CIK 0001472158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:26 UTC |
Zumwalt KurtDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001323 · form4-02142022_020228.xml · derivative · entry 1 Zumwalt Kurt · CIK 0001803266 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:18 UTC |
Hood Leroy E. MD PhDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001315 · form4-02142022_020248.xml · derivative · entry 1 Hood Leroy E. MD PhD · CIK 0001472162 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:22 UTC |
HANISH ARNOLD CDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001320 · form4-02142022_020204.xml · derivative · entry 1 HANISH ARNOLD C · CIK 0001233253 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:09 UTC |
Bumol Thomas F.Director
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001302 · form4-02142022_020236.xml · derivative · entry 1 Bumol Thomas F. · CIK 0001767077 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:15 UTC |
Demopulos Peter A MDDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001309 · form4-02142022_020209.xml · derivative · entry 1 Demopulos Peter A MD · CIK 0001472161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:05 UTC |
Aspiri RayDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001298 · form4-02142022_020258.xml · derivative · entry 1 Aspiri Ray · CIK 0001472157 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires not disclosed F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable. F2 · derivative.expiration_date: The stock option reported on this Form 4 was scheduled to vest on the day before the date of the issuer's 2022 annual meeting of the shareholders, provided that the reporting person continued to serve as a director of the issuer through such date. The reporting person retired from the issuer's board of directors in October 2021. As a result, the option was terminated without becoming exercisable. Read SEC document |
| June 11, 2021 Filed Feb 14, 2022 22:12 UTC |
Shah RajivDirector
|
GrantStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $15.81 | $0.00 |
DisclosureSEC source: 0001415889-22-001306 · form4-02142022_020217.xml · derivative · entry 1 Shah Rajiv · CIK 0001642407 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2031-06-10 F1 · security: Pursuant to Omeros Corporation's non-employee director compensation policy, on the date of each annual meeting of shareholders, each non-employee director who has served as a director for at least six months and who will continue to serve as a director after the annual meeting is automatically granted an option to purchase 7,500 shares of common stock. This Form 4 reports the annual stock option award granted to the reporting person in conjunction with the annual meeting of shareholders held on June 11, 2021. F2 · derivative.exercise_date: This option will fully vest and become exercisable on the day before the date of the 2022 annual meeting of the shareholders of Omeros Corporation, provided that the participant continues to serve as a director of the company through such date. Read SEC document |
| May 20, 2021 Filed May 21, 2021 22:45 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionStock Option (right to buy) · Derivative | 36,856 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,713 Underlying: Common Stock · 36,856 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| May 20, 2021 Filed May 21, 2021 22:45 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
SaleCommon Stock | 36,856 | $14.96 | $551,365.76 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $13.87 to $15.27; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 20, 2021 Filed May 21, 2021 22:45 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionCommon Stock | 36,856 | $4.10 | $151,109.60 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,842 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:45 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionStock Option (right to buy) · Derivative | 36,857 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · derivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,569 Underlying: Common Stock · 36,857 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:45 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
SaleCommon Stock | 36,857 | $17.07 | $629,148.99 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 2 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person on September 15, 2020 for expiring options. The trading schedule, including sale dates and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F2 · price: This transaction was executed in multiple trades at prices ranging from $16.92 to $17.60; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| May 19, 2021 Filed May 21, 2021 22:45 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionCommon Stock | 36,857 | $4.10 | $151,113.70 |
DisclosureSEC source: 0001415889-21-002642 · form4-05212021_060501.xml · nonDerivative · entry 1 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,063,843 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 08, 2021 Filed Apr 8, 2021 23:52 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionStock Option (right to buy) · Derivative | 35,206 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · derivative · entry 6 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 147,426 Underlying: Common Stock · 35,206 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
| April 08, 2021 Filed Apr 8, 2021 23:52 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
SaleCommon Stock | 35,206 | $17.76 | $625,258.56 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 4 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,026,986 F1 · kind: Open market sale pursuant to a previously established Rule 10b5-1 trading plan adopted by the reporting person for expiring options. The trading schedule, including sale periods and the number of shares to be sold, was established at the time of the trading plan's adoption in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: This transaction was executed in multiple trades at prices ranging from $17.60 to $17.96; the price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions referenced in this footnote were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Read SEC document |
| April 08, 2021 Filed Apr 8, 2021 23:52 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionCommon Stock | 35,206 | $4.10 | $144,344.60 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · nonDerivative · entry 3 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,062,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 07, 2021 Filed Apr 8, 2021 23:52 UTC |
Demopulos Gregory A MDDirector · CHAIRMAN, CEO & PRESIDENT
|
Exercise / conversionStock Option (right to buy) · Derivative | 37,407 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001415889-21-001949 · form4-04082021_040405.xml · derivative · entry 5 Demopulos Gregory A MD · CIK 0001472160 · Director · CHAIRMAN, CEO & PRESIDENT 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,632 Underlying: Common Stock · 37,407 shares Expires 2022-01-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares subject to this option vested and became exercisable over 48 monthly installments, with a vesting commencement date of April 1, 2011. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.